Literature DB >> 17931222

Pathology of udder lesions in sows.

R V Christensen1, B Aalbaek, H E Jensen.   

Abstract

In recent years an increasing frequency of sows with udder lesions has been observed during meat inspection. The frequency and pattern of affected mammary complexes were determined by inspection, palpation, and incision of udders of 640 sows at a local slaughterhouse. From representative lesions, tissue specimens were sampled for histological and bacteriological examination. Moreover, in seven problem cases immunohistochemistry was applied for the identification of Staphylococcus aureus and Arcanobacterium pyogenes. Udder lesions were recorded in 67 sows (10.5%), with mammary complex no. 7 being most frequently affected (39%). In most cases (81%), lesions were restricted to a single mammary complex. Gross lesions were characterized as focal or multiple abscesses, which most often (79%) were accompanied by dermal ulcerations. Based on histological observations and bacterial identification, two groups of lesions were identified: (I) pyogranulomatous lesions of the dermal and subcutaneous tissue caused by S. aureus; and (II) dermal and subcutaneous abscesses dominated by A. pyogenes. In neither group I nor group II lesions, the glandular mammary tissue was involved as demonstrated by immunostaining for cytokeratin, i.e. mastitis was not diagnosed in any of the cases. In conclusion, all udder lesions were caused by skin infections predominantly caused by A. pyogenes and S. aureus resulting in the development of dermal abscesses and pyogranulomatous lesions, respectively.

Entities:  

Mesh:

Year:  2007        PMID: 17931222     DOI: 10.1111/j.1439-0442.2007.00952.x

Source DB:  PubMed          Journal:  J Vet Med A Physiol Pathol Clin Med        ISSN: 0931-184X


  1 in total

1.  Comparative host specificity of human- and pig- associated Staphylococcus aureus clonal lineages.

Authors:  Arshnee Moodley; Carmen Espinosa-Gongora; Søren S Nielsen; Alex J McCarthy; Jodi A Lindsay; Luca Guardabassi
Journal:  PLoS One       Date:  2012-11-14       Impact factor: 3.240

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.